Our vision

Our vision is to be a global specialty pharmaceutical company, contributing to human health and wellbeing worldwide through innovative drug discovery and global commercialisation.

This work will be driven by leading-edge antibody technologies in the core therapeutic areas of oncology, nephrology, immunology/allergy and the central nervous system. We are currently focussing on launching pipeline products originated by Kyowa Kirin in Europe and the United States.